Abstract
Interleukin-1β is a potent pro-inflammatory cytokine that has been shown to inhibit islet β cell function as well as to activate Fas-mediated apoptosis in a nitric oxide-dependent manner. Furthermore, this cytokine is effective in recruiting lymphocytes that mediate β cell destruction in IDDM onset. The insulin-like growth factor I (IGF-I) has been shown to block IL-1β actions in vitro. We hypothesized that gene transfer of the insulin-like growth factor I to intact human islets could prevent IL-1β-induced β cell dysfunction and sensitization to Fas-triggered apoptosis activation. Intact human islets were infected with adenoviral vectors encoding IGF-I as well as β-galactosidase and enhanced green fluorescent protein as controls. Adenoviral gene transfer of human IGF-I prevented IL-1β-mediated nitric oxide production from human islets in vitro as well as the suppression of β cell function as determined by glucose-stimulated insulin production. Moreover, IGF-I gene transfer prevented IL-1β-induced, Fas-mediated apoptosis. These results suggest that locally produced IGF-I from cultured islets may be beneficial in maintaining β cell function and promoting islet survival before and following islet transplantation as a potential therapy for type I diabetes.
Similar content being viewed by others
References
Kurrer MO, Pakala SV, Hanson HL, Katz JD . Beta cell apoptosis in T cell-mediated autoimmune diabetes Proc Natl Acad Sci USA 1997 94: 213–218
Wicker LS, Todd JA, Peterson LB . Genetic control of autoimmune diabetes in the NOD mouse Annu Rev Immunol 1995 13: 179–200
Bach JF . Insulin-dependent diabetes mellitus as an autoimmune disease Endocr Rev 1994 15: 516–542
Eisenbarth GS . Molecular aspects of the etiology of type I diabetes mellitus J Diabetes Complications 1993 7: 142–150
McDaniel ML et al. Cytokines and nitric oxide in islet inflammation and diabetes Proc Soc Exp Biol Med 1996 211: 24–32
Arnush M et al. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes J Immunol 1998 160: 2684–2691
Arnush M et al. IL-1 produced and released endogenously within human islets inhibits beta cell function J Clin Invest 1998 102: 516–526
Southern C, Schulster D, Green IC . Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism FEBS Lett 1990 276: 42–44
Welsh N, Eizirik DL, Bendtzen K, Sandler S . Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase Endocrinology 1991 129: 3167–3173
Welsh N, Bendtzen K, Welsh M . Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production J Clin Invest 1995 95: 1717–1722
Eizirik DL, Tracey DE, Bendtzen K, Sandler S . An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta Diabetologia 1991 34: 445–448
Eizirik DL et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation J Clin Invest 1994 93: 1968–1974
Rabinovitch A et al. Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production J Clin Endocrinol Metab 1994 79: 1058–1062
Hostens K et al. Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release J Clin Invest 1999 104: 67–72
Corbett JA et al. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans Proc Natl Acad Sci USA 1993 90: 1731–1735
Stassi G et al. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus J Exp Med 1997 186: 1193–1200
Yamada K et al. Mouse islet cell lysis mediated by interleukin-1-induced Fas Diabetologia 1996 39: 1306–1312
Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H . Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats Diabetologia 1989 32: 126–134
Sandberg JO, Eizirik DL, Sandler S . IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice Clin Exp Immunol 1997 108: 314–317
Giannoukakis N et al. Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro Diabetes 1999 48: 1730–1736
Hill DJ, Hogg J . Growth factor control of pancreatic B cell hyperplasia Baillìeres Clin Endocrinol Metab 1991 5: 689–698
Hill DJ, Hogg J . Expression of insulin-like growth factors (IGFs) and their binding proteins (IGF BPs) during pancreatic development in rat, and modulation of IGF actions on rat islet DNA synthesis by IGF BPs Adv Exp Med Biol 1992 321: 113–120
Hill DJ et al. Somatomedin-C in human fetal pancreas. Cellular localization and release during organ culture Diabetes 1987 36: 465–471
Hill DJ, Petrik J, Arany E . Growth factors and the regulation of fetal growth (in process citation) Diabetes Care 1998 21 (Suppl. 2): B60–69
Jones JI Clemmons DR . Insulin-like growth factors and their binding proteins: biological actions Endocr Rev 1995 16: 3–34
Russell JW, Windebank AJ, Schenone A, Feldman EL . Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal (in process citation) J Neurobiol 1998 36: 455–467
Kelley KW et al. Insulin growth factor-I inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging Ann NY Acad Sci 1998 840: 518–524
Minshall C et al. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors J Immunol 1997 159: 1225–1232
Petrik J, Arany E, McDonald TJ, Hill DJ . Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor Endocrinology 1998 139: 2994–3004
Harrison M et al. Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of Langerhans: role of Fas FEBS Lett 1998 435: 207–210
Mabley JG, Belin V, John N, Green IC . Insulin-like growth factor I reverses interleukin-1beta inhibition of insulin secretion, induction of nitric oxide synthase and cytokine-mediated apoptosis in rat islets of Langerhans FEBS Lett 1997 417: 235–238
Kaino Y, Hirai H, Ito T, Kida K . Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) mice Diabetes Res Clin Pract 1996 34: 7–11
Bergerot I, Fabien N, Maguer V, Thivolet C . Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes Clin Exp Immunol 1995 102: 335–340
Bergerot I, Fabien N, Thivolet C . Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes Diabetes Metab 1996 22: 235–239
Giannoukakis N, Rudert WA, Robbins PD, Trucco M . Targeting autoimmune diabetes with gene therapy Diabetes 1999 48: 2107–2121
Csete ME et al. Adenoviral-mediated gene transfer to pancreatic islets does not alter islet function Transplant Proc 1994 26: 756–757
Csete ME et al. Efficient gene transfer to pancreatic islets mediated by adenoviral vectors Transplantation 1995 59: 263–268
Weber M et al. Adenoviral transfection of isolated pancreatic islets: a study of programmed cell death (apoptosis) and islet function J Surg Res 1997 69: 23–32
Vercammen D et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways J Exp Med 1998 188: 919–930
Fernandes-Alnemri T, Litwack G Alnemri ES . CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta- converting enzyme J Biol Chem 1994 269: 30761–30764
Casciola-Rosen L et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death J Exp Med 1996 183: 1957–1964
Lazebnik YA et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE Nature 1994 371: 346–347
Giannoukakis N et al. Infection of intact human islets by a lentiviral vector Gene Therapy 1999 6: 1545–1551
Becker TC et al. Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels J Biol Chem 1994 269: 21234–21238
Muruve DA, Manfro RC, Strom TB, Libermann TA . Ex vivo adenovirus-mediated gene delivery leads to long-term expression in pancreatic islet transplants Transplantation 1997 64: 542–546
Zhao AZ et al. Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B Proc Natl Acad Sci USA 1997 94: 3223–3228
Mauras N, Horber FF, Haymond MW . Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans J Clin Endocrinol Metab 1992 75: 1192–1197
Van Schravendijk CF, Heylen L, Van den Brande JL, Pipeleers DG . Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells Diabetologia 1990 33: 649–653
Katz LE et al. Suppression of insulin oversecretion by subcutaneous recombinant human insulin-like growth factor I in children with congenital hyperinsulinism due to defective beta-cell sulfonylurea receptor J Clin Endocrinol Metab 1999 84: 3117–3124
Eizirik DL, Skottner A, Hellerstrom C . Insulin-like growth factor I does not inhibit insulin secretion in adult human pancreatic islets in tissue culture Eur J Endocrinol 1995 133: 248–250
Hill DJ Sedran RJ, Brenner SL, McDonald TJ . IGF-I has a dual effect on insulin release from isolated, perifused adult rat islets of Langerhans J Endocrinol 1997 153: 15–25
Haddad IY et al. Modulation of adenovirus-mediated gene transfer by nitric oxide Am J Respir Cell Mol Biol 1997 16: 501–509
Beckman JS, Crapo JD . The role of nitric oxide in limiting gene transfer: parallels to viral host defenses Am J Respir Cell Mol Biol 1997 16: 495–496
Benencia F, Courreges MC . Nitric oxide and macrophage antiviral extrinsic activity Immunology 1999 98: 363–370
Bogdan C . Of microbes, macrophages and nitric oxide Behring Inst Mitt 1997 99: 58–72
Kreil TR, Eibl MM . Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo Virology 1996 219: 304–306
Pertile TL, Karaca K, Sharma JM, Walser MM . An antiviral effect of nitric oxide: inhibition of reovirus replication Avian Dis 1996 40: 342–348
Corbett JA et al. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone Autoimmunity 1993 15: 145–153
Corbett JA et al. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide J Clin Invest 1992 90: 2384–2391
Eizirik DL, Welsh N, Hellerstrom C . Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets J Clin Endocrinol Metab 1993 76: 399–403
Hogg J, Hill DJ, Han VK . The ontogeny of insulin-like growth factor (IGF) and IGF-binding protein gene expression in the rat pancreas J Mol Endocrinol 1994 13: 49–58
Baserga R . The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 1995 55: 249–252
Baserga R et al. The IGF-I receptor in cell growth, transformation and apoptosis Biochim Biophys Acta 1997 1332: F105–126
Baserga R, Resnicoff M, D'Ambrosio C, Valentinis B . The role of the IGF-I receptor in apoptosis Vitam Horm 1997 53: 65–98
Bondurant MC et al. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells J Cell Physiol 1996 168: 255–263
Feldman EL, Sullivan KA, Kim B, Russell JW . Insulin-like growth factors regulate neuronal differentiation and survival Neurobiol Dis 1997 4: 201–214
Granerus M, Schofield P, Bierke P, Engstrom W . Growth factors and apoptosis in development. The role of insulin like growth factor I and TGFbeta1 in regulating cell growth and cell death in a human teratocarcinoma derived cell line Int J Dev Biol 1995 39: 759–764
Kelley KW et al. Growth hormone, growth factors and hematopoiesis Horm Res 1996 45: 38–45
de Craen MV et al. The proteolytic procaspase activation network: an in vitro analysis Cell Death Differ 1999 6: 1117–1124
Slee EA, Adrain C, Martin SJ . Serial killers: ordering caspase activation events in apoptosis Cell Death Differ 1999 6: 1067–1074
McIlroy D, Sakahira H, Talanian RV, Nagata S . Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli Oncogene 1999 18: 4401–4408
Wolf BB, Schuler M, Echeverri F, Green DR . Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation J Biol Chem 1999 274: 30651–30656
O'Connor R . Survival factors and apoptosis Adv Biochem Eng Biotechnol 1998 62: 137–166
Singleton JR, Dixit VM, Feldman EL . Type I insulin-like growth factor receptor activation regulates apoptotic proteins J Biol Chem 1996 271: 31791–31794
Wang L et al. Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells Endocrinology 1998 139: 1354–1360
Parrizas M, Saltiel AR, LeRoith D . Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways J Biol Chem 1997 272: 154–161
Parrizas M, LeRoith D . Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product Endocrinology 1997 138: 1355–1358
Suzuki J, Kaziro Y, Koide H . Synergistic action of R-Ras and IGF-1 on Bcl-xL expression and caspase-3 inhibition in BaF3 cells: R-Ras and IGF-1 control distinct anti-apoptotic kinase pathways FEBS Lett 1998 437: 112–116
Hueber AO et al. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis (see comments) Science 1997 278: 1305–1309
Kulik G, Weber MJ . Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I Mol Cell Biol 1998 18: 6711–6718
Holst LS et al. Protein kinase B is expressed in pancreatic beta cells and activated upon stimulation with insulin-like growth factor I Biochem Biophys Res Commun 1998 250: 181–186
Hardy S et al. Construction of adenovirus vectors through Cre-lox recombination J Virol 1997 71: 1842–1849
Mittereder N, March KL, Trapnell BC . Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy J Virol 1996 70: 7498–7509
Linetsky E et al. Improved human islet isolation using a new enzyme blend, liberase Diabetes 1997 46: 1120–1123
Acknowledgements
We would like to thank the Juvenile Diabetes Foundation International Islet Distribution Program; Elina Linetsky, Alessandra Ranuncoli and Jeff Ansite for the isolation and purification of human islets as well as Christy Bruton and Bruce Baldwin for technical assistance. This work was supported in part by Public Health Service grant AR-6–2225 (PDR) and a program project grant from the Juvenile Diabetes Foundation International (MT and PDR). NG is the recipient of a post-doctoral fellowship from the Juvenile Diabetes Foundation International and a prize from the Fonds pour la formation de chercheurs et a l'aide a la recherche (Fonds FCAR) from the provincial government of Quebec, Canada.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giannoukakis, N., Mi, Z., Rudert, W. et al. Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I. Gene Ther 7, 2015–2022 (2000). https://doi.org/10.1038/sj.gt.3301333
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301333
- Springer Nature Limited
Keywords
This article is cited by
-
A gelatin hydrogel nonwoven fabric improves outcomes of subcutaneous islet transplantation
Scientific Reports (2023)
-
Advances in alginate encapsulation of pancreatic islets for immunoprotection in type 1 diabetes
Journal of Pharmaceutical Investigation (2023)
-
IGF-1 ameliorates streptozotocin-induced pancreatic β cell dysfunction and apoptosis via activating IRS1/PI3K/Akt/FOXO1 pathway
Inflammation Research (2022)
-
Probiotic mediated NF-κB regulation for prospective management of type 2 diabetes
Molecular Biology Reports (2020)
-
Advancing islet transplantation: from engraftment to the immune response
Diabetologia (2011)